Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
2,234 total articles
Abercrombie & Fitch (ANF) offers a compelling risk/reward: strong free cash flow ($384.5M), an enterprise value that still trades cheaply (EV/EBITDA ~3.8) and management returning capital via double-digit buybacks. We upgrade to Strong Buy and lay out a concrete trade plan for a 180-trading-day position.
Shoe Carnival (SCVL) is cheap, cash-rich and executing store-level initiatives that are starting to show in margins. The appointment of Cliff Sifford as interim CEO on 02/25/2026 and a clean balance sheet ($130M+ cash, debt-free) reduce execution risk. For traders willing to tolerate retail volatility, buy into the transition with a clear stop and …
Manulife (MFC) is showing the kind of operating leverage and capital discipline that keeps income-focused and value investors interested. With a market cap of about $56.6B, a P/E of 15.1, and a freshly raised common dividend, the stock looks attractive on a pullback. This trade idea sketches an actionable mid-term buy with strict risk controls and …
IREN Limited is a vertically integrated AI and crypto infrastructure operator with secured power capacity, a large Microsoft contract, and a multi-billion dollar credit facility. Recent headline-driven weakness has opened a mid-term buying opportunity around current levels. This trade idea lays out an entry at the market, a disciplined stop, and tw…
Zevra Therapeutics' initial commercial uptake of MIPLYFFA and a $150M Rare Pediatric Disease Voucher sale materially de-risk the company’s move from clinical-stage to commercial-stage rare disease franchising. With a market cap near $620M and an improving top-line setup, we recommend a tactical long position for investors willing to tolerate biotec…
Atour Lifestyle (ATAT) looks set to produce another quarter of upside versus expectations as travel demand in China remains resilient, the company keeps expanding its hotel network and management is returning cash to shareholders. We lay out a mid-term swing trade (45 trading days) to capture a likely re-rating into the 52-week range supported by d…
Crexendo (CXDO) is a compact cloud telecommunications and software company trading near $7 with a clean balance sheet, positive free cash flow and technical momentum. This trade idea lays out a mid-term (45 trading days) long with defined entry, stop and target, and explains why AI productization and software mix expansion could re-rate the stock.
ServiceNow (NOW) has been swept up in the 2026 software sell-off, but fundamentals and AI momentum argue for an upgrade. The company generates strong free cash flow, has modest leverage, and shows early signs of technical stabilization. This trade idea lays out a clear entry at $116.60, a $150 target and a $105 stop with a mid-term horizon to captu…
Kinetik Holdings (KNTK) is a Permian-focused midstream operator with a $7.38B market cap, a ~7% yield and asset connectivity that would fit neatly into a larger midstream platform. With an annualized dividend that exceeds reported EPS, strong fee-based legacy cash flows and elevated short interest, the stock is ripe for consolidation chatter. This …
BlackBerry's QNX software and IoT licensing provide a clear path to revenue leverage that the market is underappreciating. With a market cap near $2.05B, modest debt levels and positive free cash flow, the stock at $3.48 looks like a tradeable long with defined risk. We lay out an entry at $3.48, a $5.00 target tied to re-rate and licensing wins, a…
ASML is the gatekeeper of advanced lithography and remains a primary beneficiary of AI-driven chip demand. Elevated energy and recession worries raise short-term volatility, but buybacks, solid 2025 earnings growth, and a data-center capex cycle support a mid-term long trade. Plan for a controlled position: entry $1,380.00, stop $1,280.00, target $…
AT&T's stock rally looks sustainable. The Lumen fiber acquisition, reiterated 2026 guidance and a plan to return more than $45B to shareholders create a clear mid-to-long-term growth runway. Valuation is conservative (P/E ~9, EV/EBITDA ~6.8) and free cash flow coverage supports the dividend. Trade idea: go long with a disciplined stop to protect ag…
Novo Nordisk (NVO) has pulled back to the low-$30s on GLP-1 competition and headline volatility. The stock is trading at a modest P/E of 11.4, yields ~3.1%, and shows technical signs of near-term exhaustion. With average liquidity well above today's volumes and a recent pickup in short activity, a disciplined long at $38.90 targeting $52.00 (mid-te…
Floor & Decor (FND) has been marked down to roughly $60 after a year-long slide from a $95 high. Fundamentals show a profitable, low-debt retailer with meaningful free-cash-flow, but valuation metrics (PE ~31, P/FCF >100) keep the stock expensive on trailing cash generation. Near-term technicals and concentrated investor buying present an actionabl…
Nvidia's recent price consolidation is a buying opportunity. Fundamentals - cash generation, profitability, negligible leverage - remain best-in-class while technicals and short interest create asymmetric upside for disciplined traders. This trade plan uses a defined entry, stop and target over a mid-term horizon (45 trading days).
IonQ just delivered monster growth and raised 2026 guidance; a strategic foundry partnership (SkyWater) should accelerate capacity and customer uptake. At a market cap of roughly $13.2B the stock is pricey, but the business is de-risking fast enough to justify a targeted long-term trade with explicit entry, stop and target levels.
Clean Harbors sits squarely between secular tailwinds in waste treatment and recycling and a stretched valuation driven by post-recovery momentum. The company generates strong free cash flow and solid returns on equity, but trades near its 52-week high with an EV/EBITDA of 15.2 and a P/E close to 39. This trade idea targets a mid-term move that cap…
SoFi ($18.82) has pulled back from last autumn's highs but remains on a growth trajectory — 30%+ revenue growth, improving profitability and a potentially high-impact Mastercard stablecoin integration. We upgrade our rating and recommend a tactical long with strict risk controls: entry $18.82, stop $15.50, primary target $23.00 (mid-term).
Coherent (COHR) has run hard after a multibillion Nvidia tie-up and product news, but the core fundamental driver is optical component demand and order flow. The setup favors a pullback entry to ride follow-on orders and supply tightness; valuation is rich and execution risk is real, so size positions conservatively and use a defined stop.
BitMine Immersion Technologies holds a large Ethereum treasury that currently exceeds its market cap. With signs of renewed institutional interest in digital-asset treasuries and the prospect of clearer legislation, BMNR looks structurally undervalued. This trade idea lays out an entry at $20.76, a stop at $16.00, and a target of $28.00 over a mid-…
Altria offers an attractive entry point for income-oriented traders who want upside from smoke-free adoption and near-term dividend capture. The company trades at a reasonable P/E and generates strong free cash flow versus dividend obligations, while technicals and short interest suggest limited downside momentum. This trade targets a measured long…
Amplify Energy (AMPY) is a small, asset-light E&P with recent asset sales, a clean credit line and modest leverage. In an Iran-driven spike in oil prices, AMPY's valuation, cash position and leverage profile could drive a fast, outsized move. This is a high-risk, high-reward swing trade sized for mid-term upside while protecting capital with a stri…
C4 Therapeutics (CCCC) has reignited interest after Phase 1 data and a program push for cemsidomide, an IKZF1/3 degrader for multiple myeloma. The stock is trading near its 52-week high as momentum accelerates; we outline a long trade that captures upside into clinical readouts while protecting capital if the story stalls.
Compass (COMP) just crossed an important inflection point: scale from the Anywhere merger plus positive free cash flow and sub-1x price-to-sales create an asymmetric risk/reward. I recommend a long entry at $9.06 with a $7.50 stop and a $13.00 target over the next 180 trading days, driven by $225M+ annual synergies, a $203M free cash flow base, and…
Salesforce recently sold off with the broader 'SaaSpocalypse' rout, but its fundamentals - record revenue cadence, $14.4B free cash flow, and a manageable balance sheet - argue for a tactical long. This idea outlines a mid-term (45 trading days) trade: entry at $198.79, target $250.00, stop $175.00. Reward-to-risk is attractive and several near-ter…
